{"pmid":32347435,"title":"SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19.","text":["SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19.","Dig Dis Sci","Fu, Bao","Qian, Kun","Fu, Xiaoyun","32347435"],"journal":"Dig Dis Sci","authors":["Fu, Bao","Qian, Kun","Fu, Xiaoyun"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347435","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s10620-020-06285-4","keywords":["covid-19","gastrointestinal symptoms","sars-cov-2","vomiting"],"topics":["Case Report"],"weight":1,"_version_":1665441658233159681,"score":8.599203,"similar":[{"pmid":32303970,"title":"Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis.","text":["Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis.","Intern Emerg Med","Henry, Brandon Michael","de Oliveira, Maria Helena Santos","Benoit, Justin","Lippi, Giuseppe","32303970"],"journal":"Intern Emerg Med","authors":["Henry, Brandon Michael","de Oliveira, Maria Helena Santos","Benoit, Justin","Lippi, Giuseppe"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303970","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s11739-020-02329-9","keywords":["covid-19","coronavirus","diarrhea","nausea","vomiting"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664632934551781376,"score":94.34876},{"pmid":32200613,"title":"COVID-19: gastrointestinal symptoms and potential sources of 2019-nCoV transmission.","text":["COVID-19: gastrointestinal symptoms and potential sources of 2019-nCoV transmission.","A new type of coronavirus, i.e. se-vere acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly known as 2019-nCoV) appeared in December 2019 in the province of Hubei, China, and over the past four months the number of cases of infection has exceeded 240,000 worldwide, leading to a pandemia [1]. At the genetic level, 2019-nCoV is closely related to the SARS-CoV and, to a lesser extent, to MERS-CoV, which appeared as epidemiological threats in recent years in China and the Middle East, respectively. Infections with the Coronaviridae virus family in a small percentage of patients, especially in those over 60 years of age with a positive clinical history, lead to severe acute respiratory syndrome [2].","Anaesthesiol Intensive Ther","Kotfis, Katarzyna","Skonieczna-Zydecka, Karolina","32200613"],"abstract":["A new type of coronavirus, i.e. se-vere acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly known as 2019-nCoV) appeared in December 2019 in the province of Hubei, China, and over the past four months the number of cases of infection has exceeded 240,000 worldwide, leading to a pandemia [1]. At the genetic level, 2019-nCoV is closely related to the SARS-CoV and, to a lesser extent, to MERS-CoV, which appeared as epidemiological threats in recent years in China and the Middle East, respectively. Infections with the Coronaviridae virus family in a small percentage of patients, especially in those over 60 years of age with a positive clinical history, lead to severe acute respiratory syndrome [2]."],"journal":"Anaesthesiol Intensive Ther","authors":["Kotfis, Katarzyna","Skonieczna-Zydecka, Karolina"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32200613","week":"202013|Mar 23 - Mar 29","doi":"10.5114/ait.2020.93867","keywords":["2019-ncov transmission","gastrointestinal symptoms","covid-19"],"source":"PubMed","topics":["Mechanism","Transmission"],"weight":1,"locations":["Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664639760368402432,"score":91.84572},{"pmid":32320556,"title":"Late-Onset Neonatal Sepsis in a Patient with Covid-19.","text":["Late-Onset Neonatal Sepsis in a Patient with Covid-19.","N Engl J Med","Coronado Munoz, Alvaro","Nawaratne, Upulie","McMann, David","Ellsworth, Misti","Meliones, Jon","Boukas, Konstantinos","32320556"],"journal":"N Engl J Med","authors":["Coronado Munoz, Alvaro","Nawaratne, Upulie","McMann, David","Ellsworth, Misti","Meliones, Jon","Boukas, Konstantinos"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320556","week":"202017|Apr 20 - Apr 26","doi":"10.1056/NEJMc2010614","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664815087754412033,"score":75.44126},{"pmid":32307298,"title":"Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.","text":["Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.","The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise.","J Clin Neurosci","Radmanesh, Farid","Rodriguez-Pla, Alicia","Pincus, Michael D","Burns, Joseph D","32307298"],"abstract":["The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise."],"journal":"J Clin Neurosci","authors":["Radmanesh, Farid","Rodriguez-Pla, Alicia","Pincus, Michael D","Burns, Joseph D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307298","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jocn.2020.04.054","keywords":["acute necrotizing encephalopathy","adult onset still's disease","diffuse hemorrhagic encephalopathy","disseminated intravascular coagulation","hemophagocytic syndrome"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["organomegaly","cytopenia"],"e_drugs":["Triglycerides"],"_version_":1664632501560147968,"score":68.133514},{"pmid":32309266,"pmcid":"PMC7162568","title":"Abdominal Pain: A Real Challenge in Novel COVID-19 Infection.","text":["Abdominal Pain: A Real Challenge in Novel COVID-19 Infection.","COVID-19 (coronavirus disease 19) is an infectious disease caused by coronavirus 2019-nCoV. Since its detection in China at the end of 2019, the novel coronavirus has rapidly spread throughout the world and has caused an international public health emergency. The most common manifestation is flu-like symptoms. Mild infections usually improve within a few days, but COVID-19 can cause severe pneumonia with acute respiratory distress syndrome and death. Gastrointestinal symptoms are less common but possible and more difficult to recognize as part of a COVID-19 syndrome. In line with the current opinion of the WHO, we strongly believe that preventive measures and early diagnosis of COVID-19 are crucial to interrupt virus spread and avoid local outbreaks. We report the cases of COVID-19 patients admitted to our Emergency Department who complained of gastrointestinal symptoms at admission. LEARNING POINTS: The novel COVID-19 infection is a severe public health problem which is causing an increasing number of deaths worldwide.Although uncommon, there may be a relationship between gastrointestinal symptoms and COVID-19, as reported in recent studies.Early detection and isolation of patients with COVID-19 infection is the only way to control and limit the global spread of this virus.","Eur J Case Rep Intern Med","Poggiali, Erika","Ramos, Pau Mateo","Bastoni, Davide","Vercelli, Andrea","Magnacavallo, Andrea","32309266"],"abstract":["COVID-19 (coronavirus disease 19) is an infectious disease caused by coronavirus 2019-nCoV. Since its detection in China at the end of 2019, the novel coronavirus has rapidly spread throughout the world and has caused an international public health emergency. The most common manifestation is flu-like symptoms. Mild infections usually improve within a few days, but COVID-19 can cause severe pneumonia with acute respiratory distress syndrome and death. Gastrointestinal symptoms are less common but possible and more difficult to recognize as part of a COVID-19 syndrome. In line with the current opinion of the WHO, we strongly believe that preventive measures and early diagnosis of COVID-19 are crucial to interrupt virus spread and avoid local outbreaks. We report the cases of COVID-19 patients admitted to our Emergency Department who complained of gastrointestinal symptoms at admission. LEARNING POINTS: The novel COVID-19 infection is a severe public health problem which is causing an increasing number of deaths worldwide.Although uncommon, there may be a relationship between gastrointestinal symptoms and COVID-19, as reported in recent studies.Early detection and isolation of patients with COVID-19 infection is the only way to control and limit the global spread of this virus."],"journal":"Eur J Case Rep Intern Med","authors":["Poggiali, Erika","Ramos, Pau Mateo","Bastoni, Davide","Vercelli, Andrea","Magnacavallo, Andrea"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32309266","week":"202017|Apr 20 - Apr 26","doi":"10.12890/2020_001632","keywords":["covid-19 infection","abdominal pain","diarrhoea","gastrointestinal symptoms"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664632501338898432,"score":67.88625}]}